Hoelscher Paul W.'s Form 4 filing
Horizon Therapeutics Public Ltd Co (HZNP) · filed Dec 30, 2021
- Accession no.
- 0001209191-21-071650
- Filed
- Dec 30, 2021
- Trade date
- Aug 25-Dec 28, 2021
- Filing delay
- 127 daysLate
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 5 non-derivative transactions and 1 derivative transaction. Open-market sales total $943.3K. It was filed 127 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Hoelscher Paul W.CIK 0001611468 | Officer (EVP, CFO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 25, 2021 | Ordinary Shares | GGiftDisposed | −6,163 | $0.00 | $0 | 2,098 | Direct | |
| Aug 25, 2021 | Ordinary Shares | GGiftAcquired | +6,163 | $0.00 | $0 | 178,389 | Indirect | |
| Dec 3, 2021 | Ordinary Shares | GGiftDisposed | −1,049 | $0.00 | $0 | 1,049 | Direct | |
| Dec 28, 2021 | Ordinary Shares | MOption exerciseAcquired | +8,575 | $15.96 | +$136,857 | 9,624 | Direct | |
| Dec 28, 2021 | Ordinary Shares | SSaleDisposed | −8,575 | $110.00 | −$943,250 | 1,049 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 28, 2021 | Ordinary Shares | MOption exerciseDisposed | −8,575 | $0.00 | $0 | 56,365 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.